ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

CELU Celularity Inc

3,29
0,17 (5,45%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Celularity Inc CELU NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,17 5,45% 3,29 22:30:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,21 3,08 3,32 3,29 3,12
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
22.4.202414:00GLOBECelularity Inc. to Host Investor and Analyst Research &..
19.4.202423:30GLOBECelularity Inc. Announces Receipt of Nasdaq Notice Regarding..
18.4.202422:30GLOBECelularity Abstract “Emerging Technologies for the..
15.4.202414:00GLOBECelularity Announces Net Sales Trending Ahead of..
08.4.202415:00GLOBECelularity to Present Data Showing Senescent Cell..
26.3.202414:00GLOBECelularity Receives Healthcare Common Procedure Coding..
20.3.202414:15GLOBECelularity Submits Request to U.S. FDA for Orphan Drug..
14.3.202414:15GLOBECelularity CEO to Present on Cell Therapy’s Potential to..
12.3.202414:20GLOBECelularity CEO to Present Keynote Address at 2024 Society..
07.3.202415:35GLOBECelularity to Present Data Showing Cancer Tumor Reduction by..
26.2.202423:15EDGAR2Form 8-K - Current report
23.2.202422:10GLOBECelularity Announces 1-for-10 Reverse Stock Split
22.2.202415:05EDGAR2Form 8-K - Current report
22.2.202403:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202403:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202403:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202403:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202422:05GLOBECelularity’s Tri-layer Decellularized, Dehydrated Human..
12.2.202422:15EDGAR2Form 8-K - Current report
02.2.202412:01EDGAR2Form DEF 14A - Other definitive proxy statements
01.2.202415:00GLOBECelularity Announces Net Sales Expectations for First..
25.1.202415:00GLOBECelularity and Genting Leaders Comments on Closing $21..
23.1.202412:02EDGAR2Form PRE 14A - Other preliminary proxy statements
18.1.202419:40GLOBECelularity Releases CEO Letter to Shareholders
17.1.202423:15EDGAR2Form SC 13D/A - General statement of acquisition of..
17.1.202422:14EDGAR2Form 8-K - Current report
09.1.202422:49EDGAR2Form 8-K - Current report
04.1.202419:00GLOBECelularity Confirms Commercialization Agreement with..
03.1.202418:00GLOBECelularity Announces Net Sales and Total Revenue..
29.12.202322:47EDGAR2Form 8-K - Current report
24.11.202319:46EDGAR2Form 8-K - Current report
24.11.202319:15GLOBECelularity Inc. Announces Receipt of Nasdaq Notice Regarding..
18.10.202315:00GLOBECelularity Announces Commercial Biomaterial Products..
17.10.202302:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.10.202301:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
19.9.202315:25EDGAR2Form 8-K - Current report
07.9.202322:21EDGAR2Form 8-K - Current report
07.9.202322:10GLOBECelularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to..
29.8.202315:15EDGAR2Form 8-K - Current report
29.8.202315:00GLOBECelularity Announces Multi-Year Research Collaboration..
25.8.202322:06EDGAR2Form 8-K - Current report
14.8.202323:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04.8.202322:16EDGAR2Form 8-K - Current report
28.7.202322:27EDGAR2Form 8-K - Current report
28.7.202322:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27.7.202315:07GLOBECelularity Inc. Announces $3 Million Registered Direct..
27.7.202315:00GLOBECelularity and Verséa Ophthalmics Announce Exclusive U.S...
19.7.202318:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.7.202315:00GLOBECelularity Human Placental-Derived Advanced Biomaterials..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock